Oxford University has today paused trials of its coronavirus vaccine in children while regulators probe the jab s link to rare blood clots.
A spokesperson for the prestigious university said the move was precautionary and that there were no health issues among any of the youngsters involved in the trial.
Oxford began studying the vaccine in five-to-17-year-olds in February, with the aim of eventually scaling up the trial and testing it in 200 people.
But scientists have stopped recruiting new volunteers and it is not clear how many children have already been given a dose.
Oxford is waiting for more information from the UK s regulator, the Medicines and Healthcare products Regulatory Agency, before restarting the study, the Wall Street Journal reported.
Will the US EVER get AstraZeneca s Covid vaccine?
dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.
AstraZeneca s Covid vaccine may not be suitable for young people
dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.
Professor Linda Bauld of Edinburgh University said there is no evidence that the uptake of AstraZeneca jab is slowing in the UK
There is no evidence that the uptake of AstraZeneca jab is slowing in the UK despite European countries pausing their rollout of the company s vaccine, a public health expert has claimed.
Professor Linda Bauld of Edinburgh University said all studies indicated the jab was safe and effective, while the fact different countries were reviewing their position was a sign that the system was working.
Germany has suspended use of the AstraZeneca vaccine for people aged under 60 due to fears of a link with rare blood clots.